Press Releases
 
Anticonvulsants Drug Market Dynamics, Forecast, Analysis and Supply Demand 2017 – 2025

, 11 July 2019 -- Anticonvulsants Drug Market is driven by Rising prevalence of epilepsy, Increase in number of migraine, rise in fibromyalgia and increasing sales of existing blockbuster drug Lyrica.

The first line of treatment in pain management usually involves the use of pharmaceuticals from various therapeutic classes such as antidepressants, opioids, NSAIDs, anticonvulsants, anesthetics, and other non-narcotic analgesics. Anticonvulsants, also known as antiepileptic drugs, were developed primarily for the treatment of epileptic seizures. However, leading anticonvulsant drugs such as Lyrica (pregabalin) and Neurontin (gabapentin) have also been approved for the management of various pain indications including fibromyalgia, migraine and neuropathic pain. These approvals are responsible for the increasing importance of anticonvulsants in the management of various pain indications. The overall market for anticonvulsants is highly genericized; however, the market for anticonvulsants for pain management application is dominated by Lyrica, the only branded pharmaceutical among the currently marketed drugs.

Report Overview @ https://www.transparencymarketresearch.com/anticonvulsants-drug-market.html

Of the major anticonvulsant drugs currently marketed, Lyrica (pregabalin), Neurontin (gabapentin), Topamax (topiramate), Depakote (divalproex), and Carbatrol/Tegretol (carbamazepine) are indicated for management of various types of pain. In 2012, Lyrica registered sales of US$ 5,111 Mn, of which 74% constituted revenue from its pain management indication. Since all the other molecules are generic and have negligible contribution in the pain management application, the market will be driven and dominated by the sales of existing blockbuster drug Lyrica, which constituted 73.4% share of the total market in 2011. The drug was initially set to lose its patent exclusivity in 2015, which would have negatively impacted the market rendering it completely generic. However, Pfizer has obtained market exclusivity for the drug and its use in pain management through to 2018, and is therefore expected to maintain its leadership position.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22973

Rising prevalence of epilepsy is the key driver of the anticonsultants drug market. Anticonvulsants drug is not only consumed in case of epileptic seizures, but also for pain management in migraine, and fibromyalgia. This boosts the anticonvulsants drug market. Availability of alternative options for pain management acts as a major restraint of the market. Other pain management methods include the use of medical devices such as analgesic pumps and minimally invasive procedures such as denervation or rhizotomy. Pain management implants and devices such as neuromodulators are gaining market acceptance among medical professionals, while acupuncture and acupressure are world-renowned pain relief techniques along with physiotherapy that people adopt. Other devices included in pain relief are transcutaneous electrical nerve stimulation (TENS) that delivers mild shocks to nerves in order to block pain messages to the brain. Hence, competition in the market from other improved pain management methods, devices, and other drugs can also hamper the anticonvulsants drug market. The anticonvulsants drug market has been segmented based on therapeutic class, disease indication, formulation, distribution channel, and region.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=22973

In terms of region, the anticonvulsants drug market has been classified into Asia Pacific, Europe, Middle East & Africa, North America, and Latin America. Key players in the anticonvulsant drug market are Abbott Laboratories, Teva Pharmaceutical Industries Ltd., Johnson & Johnson Services, Inc., Novartis AG, Pfizer, Inc., Valeant Pharmaceuticals International, Inc., Sanofi, UCB, Shire plc., and Astrazeneca plc.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email:

Website: https://www.transparencymarketresearch.com

# # #


Submitted by hawer on Thursday, 11 July 2019 at 7:01 PM
Category: Health Care & Medical
 
Related News

Marfan Syndrome Treatment Market to Witness a Pronounce Growth by 2026
Wednesday, 24 Jul 2019

Gene Synthesis Market to Witness a Pronounce Growth by 2026
Wednesday, 24 Jul 2019

Cryotherapy Market Size, Share & Trend | Industry Analysis Report, 2026
Wednesday, 24 Jul 2019

GnRH Agonists & Antagonists Market Size, Share & Trend | Industry Analysis Report, 2026
Wednesday, 24 Jul 2019

Infliximab Market to Witness a Pronounce Growth by 2026
Wednesday, 24 Jul 2019

Related Events

Neuropsychiatric Drug Development Summit Boston
Tuesday, 23 Jul 2019

Cardiovascular and Respiratory Disease Summit (CARPS)
Wednesday, 24 Jul 2019

Orthopaedics for the Primary Care Practitioner and Rehabilitation Therapist
Friday, 26 Jul 2019

Oncology Update 2019 CME Conference - Los Angeles
Saturday, 27 Jul 2019

The National Conference on Wilderness Medicine Big Sky Resort, Montana
Saturday, 27 Jul 2019

Latest News

Marfan Syndrome Treatment Market to Witness a Pronounce Growth by 2026
Wednesday, 24 Jul 2019

Gene Synthesis Market to Witness a Pronounce Growth by 2026
Wednesday, 24 Jul 2019

Cryotherapy Market Size, Share & Trend | Industry Analysis Report, 2026
Wednesday, 24 Jul 2019

Limb Salvage Surgery Market Overview and Regional Outlook Study 2018 – 2026
Wednesday, 24 Jul 2019

GnRH Agonists & Antagonists Market Size, Share & Trend | Industry Analysis Report, 2026
Wednesday, 24 Jul 2019

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Wednesday, 24 July 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Neuropsychiatric Drug Development Summit Boston
  • Cardiovascular and Respiratory Disease Summit (CARPS)
  • 61st London International Youth Science Forum
  • 20th International Union for Quaternary Research Congress (INQUA 2019)
  • Palo Alto Networks: Cyber Range - UK Public Sector

  • Latest Jobs
    Sorry, there are currently no entries posted here.